AMASS Botanics (2021)

About this raise

AMASS Botanics, with a $75 million pre-money valuation, is testing the waters on SeedInvest. It is a botanical body care and spirits brand that makes clean botanics suiting the modern lifestyle. The self-care portfolio contains hand sanitizer, hand soap, bath salts, and lotion, while the beverage portfolio consists of botanic gin and vodka, botanic non-alcoholic spirit, cannabis spirit, and Aperitivo. Mark Thomas Lynn founded AMASS Botanics in 2016 and has raised over $15 million in previous rounds of financing. The proceeds of the current crowdfunding round, with a minimum raise of $25,000 and a maximum raise of $107,000, will target marketing, team expansion, and new product development. AMASS Botanics has an $8 million revenue run rate as of the fourth quarter of 2020. The business reported a 549% year-over-year growth in revenue from 2019 to 2020.

Expand

Investment Overview

Invested this round: $3,361,732

Deal Terms

Total Commitments

Platform
SeedInvest
Start Date
03/19/2021
Close Date
09/11/2021
Min. Goal
Funded
Max Goal
Funded
Min. Investment

$499

Security Type

Equity - Preferred

SEC Filing Type

Test the Waters    Open SEC Filing

Price Per Share

$3.87

Pre-Money Valuation

$75,000,000

Company & Team

Company

Year Founded
2016
Industry
Alcohol, Tobacco, & Recreational Drugs
Tech Sector
Non-Tech
Location
LOS ANGELES, California
Company Website
Visit Website

Team

Financials

Financials are not currently available for this company. This may occur if the company is still Testing the Waters, is a Regulation D offering, or if the financials are still under review and being confirmed by our team. For Reg CF and Reg A+ raises, please check back later.

Upgrade to gain access

Pay Monthly
Annually (2 months free)

Edge

$12.50 /month
billed annually
Free portfolio tracking, data-driven ratings, AI analysis and reports
Plan Includes:
Everything in Free, plus
Company specific Kingscrowd ratings and analyst reports
Deal explorer and side-by-side comparison
Startup exit and failure tracking
Startup market filters and historical industry data
Advanced company search ( with ratings)
Get Edge Annual
Already a member? Log in here.

Company Funding & Growth

Funding history

Offering Name Close Date Platform Valuation Total Raised Security Type Status Reg Type
AMASS Brands 12/31/2025 DealMaker Securities $110,000,000 $94,164 Equity - Common Active RegCF
AMASS Botanics 12/21/2024 StartEngine $100,000,000 $0 Equity - Preferred Not Funded RegCF
AMASS Botanics 01/28/2022 SeedInvest $75,000,000 $5,132,879 Equity - Preferred Funded RegCF / RegD 506(c)
AMASS Botanics 09/11/2021 SeedInvest $75,000,000 $3,361,732 Equity - Preferred Funded Test the Waters
Create a free account today to gain access to Kingscrowd analytics.

Growth Charts

Revenue History

Note: Revenue data points reflect the latest of either the most recent fiscal year's financials, or updated revenues directly from the founder, at each raise's close date.

Valuation History

Price per Share History

Note: Share prices shown in earlier rounds may not be indicative of any stock splits.

Employee History

Founders: enhance your startup's credibility on Kingscrowd. Create an account to claim this raise page.
Add to portfolio
AMASS Botanics on SeedInvest
Platform: SeedInvest
Security Type: Equity - Preferred
Valuation: $75,000,000
Price per Share: $3.87

Follow company

Follow AMASS Botanics on SeedInvest

Buy AMASS Botanics's Deal Report

Warning: according to the close date for this deal, AMASS Botanics may no longer be accepting investments.

AMASS Botanics Deal Report

Get Kingscrowd's comprehensive report on AMASS Botanics including:

  • How our proprietary algorithm rates their current capital raise (1-5 stars)
  • Detailed price, market, team, differentiators, performance, and risk ratings
  • Whether AMASS Botanics is undervalued or overvalued
  • Scores on the founding team and key personnel's background and expertise

Buy the AMASS Botanics deal report for only $10!

Email address:
Looking to buy more than one deal report? Get unlimited reports by upgrading to Edge